VX-222
Cat.No:IV0450 Solarbio
CAS:1026785-59-0
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Solid
Qty:
Size:
{{cart_num}}
My CartCAS:1026785-59-0
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Solid
Qty:
Size:
CAS | 1026785-59-0 |
Name | VX-222 |
Molecular Formula | C25H35NO4S |
Molecular Weight | 445.61 |
Solubility | Soluble in DMSO |
Purity | ≥98% |
Appearance | Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
SMILES | O=C(C1=C(N([C@@H]2CC[C@H](O)CC2)C([C@H]3CC[C@H](C)CC3)=O)C=C(C#CC(C)(C)C)S1)O |
Target Point | HCV |
Passage | Anti-infection |
Background | VX-222 is a novel HCV polymerase selective inhibitor. |
Biological Activity | VX-222 are nonnucleoside inhibitors (NNIs) that bind to the thumb II allosteric pocket of the hepatitis C virus (HCV) RNA-dependent RNA polymerase. [1] |
In Vitro | VX-222 inhibited the 1b/Con1 HCV subgenomic replicon,with 50% effective concentrations(EC(50)s)of 5 nM.VX-222 bind to the HCV polymerase with dissociation constants of 17 nM. [1] |
Data Literature Source | [1]. Yi G,Deval J,et al. Biochemical study of the comparative inhibition of hepatitis C virus RNA polymerase by VX-222 and filibuvir. Antimicrob Agents Chemother. 2012;56(2):830-837. |
Unit | Bottle |
Specification | 5mg 10mg |
VX-222 是新型的HCV聚合酶选择性抑制剂。
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.